Wells Fargo’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-139
| Closed | – | – | 7321 |
|
|
2020
Q2 | $0 | Hold |
139
| – | – | ﹤0.01% | 7177 |
|
|
2020
Q1 | $0 | Buy |
139
+39
| +39% | +$80 | ﹤0.01% | 7191 |
|
|
2019
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 6956 |
|
|
2019
Q3 | $1K | Sell |
100
-162
| -62% | -$1.08K | ﹤0.01% | 6330 |
|
|
2019
Q2 | $3K | Sell |
262
-1,136
| -81% | -$20.9K | ﹤0.01% | 6147 |
|
|
2019
Q1 | $38K | Buy |
1,398
+1
| +0.1% | +$25 | ﹤0.01% | 5389 |
|
|
2018
Q4 | $31K | Sell |
1,397
-8
| -0.6% | -$313 | ﹤0.01% | 5667 |
|
|
2018
Q3 | $78K | Buy |
1,405
+114
| +9% | +$7.28K | ﹤0.01% | 5455 |
|
|
2018
Q2 | $92K | Sell |
1,291
-298
| -19% | -$21K | ﹤0.01% | 5415 |
|
|
2018
Q1 | $97K | Buy |
1,589
+111
| +8% | +$9.74K | ﹤0.01% | 5320 |
|
|
2017
Q4 | $186K | Sell |
1,478
-675
| -31% | -$86.4K | ﹤0.01% | 4994 |
|
|
2017
Q3 | $294K | Buy |
2,153
+268
| +14% | +$35.8K | ﹤0.01% | 4689 |
|
|
2017
Q2 | $268K | Sell |
1,885
-1,803
| -49% | -$279K | ﹤0.01% | 4603 |
|
|
2017
Q1 | $678K | Sell |
3,688
-3,410
| -48% | -$382K | ﹤0.01% | 4049 |
|
|
2016
Q4 | $572K | Buy |
7,098
+6,385
| +896% | +$505K | ﹤0.01% | 4106 |
|
|
2016
Q3 | $55K | Sell |
713
-7
| -1% | -$561 | ﹤0.01% | 5252 |
|
|
2016
Q2 | $62K | Sell |
720
-161
| -18% | -$14.8K | ﹤0.01% | 5112 |
|
|
2016
Q1 | $82K | Buy |
881
+131
| +17% | +$13.1K | ﹤0.01% | 4976 |
|
|
2015
Q4 | $151K | Sell |
750
-308
| -29% | -$61.5K | ﹤0.01% | 4636 |
|
|
2015
Q3 | $158K | Sell |
1,058
-10,412
| -91% | -$7.64M | ﹤0.01% | 4596 |
|
|
2015
Q2 | $10.9M | Buy |
11,470
+1,297
| +13% | +$1.06M | ﹤0.01% | 1844 |
|
|
2015
Q1 | $7.46M | Buy |
10,173
+3,705
| +57% | +$2.78M | ﹤0.01% | 2104 |
|
|
2014
Q4 | $5.14M | Sell |
6,468
-4,568
| -41% | -$2.46M | ﹤0.01% | 2319 |
|
|
2014
Q3 | $4.4M | Sell |
11,036
-6,729
| -38% | -$1.8M | ﹤0.01% | 2408 |
|
|
2014
Q2 | $4.79M | Sell |
17,765
-1,416
| -7% | -$304K | ﹤0.01% | 2363 |
|
|
2014
Q1 | $4.18M | Buy |
19,181
+5,675
| +42% | +$1.58M | ﹤0.01% | 2440 |
|
|
2013
Q4 | $3.65M | Buy |
+13,506
| New | +$3.22M | ﹤0.01% | 2490 |
|
Wells Fargo's TTPH Position: Q3 2020 in Review
Wells Fargo sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 139 shares.
Wells Fargo first reported a position in TTPH in Q4 2013 and held it in 27 quarters. The position peaked at $10.9M in Q2 2015. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.
- Wells Fargo reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Wells Fargo sold 139 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020.
- Wells Fargo first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2013 and held it in 27 quarters.
- Wells Fargo's Tetraphase Pharmaceuticals, Inc. position peaked at $10.9M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.
Based on Wells Fargo's 13F filing for Q3 2020, filed 5 Nov 2020.